ライフサイエンスコーパス: receptor antagonist

1 ns blocker), control, and picrotoxin (GABA-A receptor antagonist).

2 receptor antagonist) but not AF-DX 116 (M(2) receptor antagonist).

3 62, a calcitonin gene-related peptide (CGRP) receptor antagonist.

4 by experiments with MIN6 cells, and a GLP-1 receptor antagonist.

5 tidepressant effects were blocked by an AMPA receptor antagonist.

6 A-induced calcium signal is dependent on P2Y receptor antagonist.

7 but not with an angiotensin II type 1 (AT1) receptor antagonist.

8 intrapericardial naloxone, a specific opioid receptor antagonist.

9 re IL-1alpha and less IL-1RA, a natural IL-1 receptor antagonist.

10 al A-317491, a selective P2X(2/3) and P2X(3) receptor antagonist.

11 plasma concentrations of CP101,606, a GluN2B receptor antagonist.

12 ion of scopolamine, a muscarinic-cholinergic receptor antagonist.

13 E inhibitor but not by an angiotensin II AT1 receptor antagonist.

14 ine, a nonselective acetylcholine muscarinic receptor antagonist.

15 inically relevant dose/schedule of any IL-17-receptor antagonist.

16 IL-18, and IL-1alpha but low amounts of IL-1 receptor antagonist.

17 by treatment with IL-4 or a beta-adrenergic receptor antagonist.

18 systemic pretreatment with a vasopressin-1a-receptor antagonist.

19 an be used to biochemically define a sigma-1 receptor antagonist.

20 eating is attenuated by dopamine lesions or receptor antagonists.

21 tamine and other N-methyl-D-aspartate (NMDA) receptor antagonists.

22 beta-adrenergic receptor and angiotensin II receptor antagonists.

23 5 inhibitors, sodium nitrite and endothelin receptor antagonists.

24 ncluding beta-blockers and mineralocorticoid receptor antagonists.

25 s of fluorinated nonxanthine A(2B) adenosine receptor antagonists.

26 R was only consistently increased by GABA(A) receptor antagonists.

27 oid synthesis inhibitors, and glucocorticoid receptor antagonists.

28 rs, with effects prevented by selective GABA receptor antagonists.

29 mptoms of PD that were rescued by adrenergic receptor antagonists.

30 rocess extension, which was blocked by P2Y12 receptor antagonists.

31 sacubitril/valsartan, and mineralocorticoid receptor antagonists.

32 ocked by joint application of P2Y1 and P2Y13 receptor antagonists.

33 the addition of an SP receptor (neurokinin-1 receptor) antagonist.

34 mine, a non-competitive N-methyl-D-aspartate receptor antagonist(2,3), provide rapid and long-lasting

35 nsin system inhibitor, and mineralocorticoid receptor antagonist; 40.3% versus 30.4% respectively, P<

36 utamate receptor antibody, and the glutamate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dion

37 d significantly more often mineralocorticoid receptor antagonists (64.5% versus 43.8%), ivabradine (8

38 ceptor antagonist NF449, the purinergic P2X7 receptor antagonist A438079, and azidothymidine (AZT) we

39 We have previously shown that amylin receptor antagonist, AC253, improves spatial memory in A

40 phoresis to eject small amounts of glutamate receptor antagonists, aiming to perturb, but not abolish

41 CSF CRP in turn correlated with CSF cytokine receptors/antagonists (all p < 0.05).

42 ich bilateral aDLS infusions of the dopamine receptor antagonist alpha-flupenthixol (0, 5, 10, and 15

43 stry required to advance small molecule CGRP receptor antagonists, also called gepants, including the

44 terneurons or locally introducing DA or GABA receptor antagonists alters kinship preference.

45 ficacy and safety of the association of IL-1 receptor antagonist anakinra plus methylprednisolone in

46 Ex vivo, the addition of IL-1 receptor antagonist anakinra to whole blood reduced stap

47 Ex vivo, addition of the IL-1 receptor antagonist anakinra to whole blood reduced stap

48 patients early in the disease with the IL-1 receptor antagonist, anakinra.

49 ith H1 and H2 receptor blockers, leukotriene receptor antagonist and consideration for prolonged redu

50 lectrophysiological response to an adenosine receptor antagonist and increased adenosine receptor gen

51 of purinergic signaling on hDPSC, purinergic receptor antagonists and an ectonucleotidase inhibitor w

52 nd hepatocytes; this response was negated by receptor antagonists and GPR55 gene silencing in L6 myot

53 Muscarinic M(3) receptor antagonists and inverse agonists displaying hig

54 ed to the development of small molecule CGRP receptor antagonists and monoclonal antibodies targeting

55 blocker, beta-blocker, and mineralocorticoid receptor antagonist) and outcomes of patients with worse

56 wn product 150, interleukin 6, interleukin 1 receptor antagonist, and c-reactive protein were measure

57 , we administered montelukast, a leukotriene receptor antagonist, and diabetes-related retinal pathol

58 yte colony-stimulating factor, interleukin 1 receptor antagonist, and vascular endothelial growth fac

59 re attenuated by an NF-kappaB inhibitor, LPA receptor antagonists, and inhibitors of phosphoinositide

60 e D(2)R antagonism or nonselective D(2)-like receptor antagonists, and is likely mediated by facilita

61 Histamine H1 receptor antagonists (antihistamines) are recommended as

62 3100) is a potent second-generation androgen receptor antagonist approved for the treatment of castra

63 t inhibitory effects induced by oral P2Y(12) receptor antagonists are delayed in patients with ST-seg

64 H(4) receptor antagonists are potential novel treatments for

65 anced prostate cancers resistant to androgen receptor antagonists are still susceptible to nontoxic B

66 ting beta(2) agonists/long-acting muscarinic receptor antagonists as the preferred treatment option f

67 e-like diuretic and an MR (mineralocorticoid receptor) antagonist, at maximal or maximally tolerated

68 ing a low dose of the selective endothelin A receptor antagonist atrasentan reduces albuminuria witho

69 bile-duct ligated (BDL) rats, whereas 5HTR2B receptor antagonists attenuate liver fibrosis (LF) in mi

70 ng Smoothened (Smo), while Shh mRNA or a CB1 receptor antagonist attenuated CB-induced birth defects.

71 Pre-treatment with SKF-83566, a D1 receptor antagonist, attenuated GBP-induced CPP.

72 The findings suggest that an NMDA receptor antagonist attenuates corticosteroid effect in

73 idine, although not by the 1 mum of the CGRP receptor antagonist BIBN4096bs.

74 In the presence of 0.3 mum Y1 receptor antagonist BIBP3226, BIBN4096bs partly inhibite

75 A receptor antagonist MK-801 and the GABA(A) receptor antagonist bicuculline methiodide while recordi

76 lly dense (1.64 mcbits/ angstrom(3)) GABA(A) receptor antagonist bilobalide, intermediates en route t

77 Coadministration of a P2Y6 receptor antagonist blocked the effect of PGE(2)-G, indi

78 Instead, it functions as a receptor antagonist, blocking the inhibitory activity of

79 intradermal administration of A5G27, a CD44 receptor antagonist, both attenuated antihyperalgesia in

80 nted and reversed by i.v. iron and by the ET receptor antagonist BQ-123.

81 hese effects were reversed by DAU 5884 (M(3) receptor antagonist) but not AF-DX 116 (M(2) receptor an

82 LA administration of a low dose of a GABA(A) receptor antagonist, but not an NMDA/AMPA/kainate recept

83 Intranasal administration of the adenosine receptor antagonist caffeine substantially enhanced the

84 Ketamine, an N-methyl-d-aspartate (NMDA) receptor antagonist, can rapidly alleviate depressive sy

85 nd without co-administration of histamine H1 receptor antagonist, cetirizine, and cysteinyl-leukotrie

86 ed with vehicle, alphaCGRP, or the alphaCGRP receptor antagonist CGRP8-37.

87 Consistently, AMPA receptor antagonist CNQX or calcineurin inhibitor FK506

88 or-neprilysin inhibitor+BB+mineralocorticoid receptor antagonist combination therapies have the highe

89 eptide Leu-Asp-Phe-Ile (LDFI), a full leptin-receptor antagonist, completely reversed the leptin-medi

90 ong PPI reports when compared to histamine-2 receptor antagonist control group.

91 of DAMGO or by application of the mu-opioid receptor antagonist CTAP, suggesting an inhibitory long-

92 nerenone is a nonsteroidal mineralocorticoid receptor antagonist currently in phase III clinical tria

93 X purinergic pathway by a broad-spectrum P2X receptor-antagonist delayed the progression of the dystr

94 ration of a peripherally restricted oxytocin receptor antagonist did not reverse the effect of intran

95 cium channel blockers, and mineralocorticoid receptor antagonists did not achieve significant reducti

96 The combination therapy of docetaxel and C3 receptor antagonist disrupted the mtDNA/C3a paracrine lo

97 analysis revealed that a group of glutamate receptor antagonists enhances branching and network conn

98 The androgen receptor antagonist enzalutamide was associated with mor

99 tone nor the more specific mineralocorticoid receptor antagonist eplerenone affected XPB protein leve

100 re blocked by applying the mineralocorticoid receptor antagonist eplerenone.

101 ious research suggests the mineralocorticoid receptor antagonist, eplerenone, is effective for treati

102 r ERbeta: DPN); or non-selective sex hormone receptor antagonists (ER/ICI 182,780, or progesterone re

103 IP(3-30)NH(2) and the well-established GLP-1 receptor antagonist exendin(9-39)NH(2) During 4-h oral g

104 Oral P2Y(12) receptor antagonists exhibit delayed onset of platelet i

105 he nonsteroidal, selective mineralocorticoid receptor antagonist finerenone on kidney and cardiovascu

106 ided in five groups (n = 10/group): androgen receptor antagonist (flutamide); estrogen receptor antag

107 all-molecule calcitonin gene-related peptide receptor antagonist for acute migraine treatment.

108 tion and Patient Outcomes], TRACER [Thrombin Receptor Antagonist for Clinical Event Reduction in Acut

109 ighlighting the potential benefits of 5-HT2C receptor antagonists for both reduction of motor side ef

110 Likewise, receptor antagonists for PGE(2) (EP(2) and EP(4)) and pr

111 en receptor antagonist (flutamide); estrogen receptor antagonist (fulvestrant); TES supplementation;

112 glucoregulatory hormones using the novel GIP receptor antagonist GIP(3-30)NH(2) and the well-establis

113 r signaling pathway, as the aryl hydrocarbon receptor antagonist GNF-351 modified approximately 200 g

114 Although glucagon receptor antagonists (GRAs) have great potential as anti

115 Importantly, pretreatment with the insulin receptor antagonist, GSK1838705, significantly suppresse

116 Use of PPIs and histamine 2-receptor antagonists (H2RA) during the year before the i

117 ffects on cAMP levels but G protein estrogen receptor antagonists had little effect on responses to a

118 amined the effect of a single dose of the D2 receptor antagonist haloperidol (2 mg) on temporal disco

119 mined the effects of a single dose of the D2 receptor antagonist haloperidol on temporal discounting

120 he dopamine precursor L-dopa, 2 mg of the D2 receptor antagonist haloperidol, and placebo.

121 Ketamine, an NMDA receptor antagonist, has emerged as a new rapid-acting a

122 , a gamma-aminobutyric acid type A (GABA(A)) receptor antagonist, has previously been reported to inh

123 all molecule calcitonin gene-related peptide receptor antagonist, has shown efficacy in the acute tre

124 ptake inhibitors, tegaserod, and histamine-2 receptor antagonists have benefit as either primary ther

125 Endothelin receptor antagonists have revolutionized the treatment o

126 ) (53-fold) and an increase in interleukin-1 receptor antagonist (IL-1ra) (5-fold) were observed.

127 ion: two specific receptor antagonists (IL-1 receptor antagonist (IL-1Ra) and IL-36 receptor antagoni

128 Cases had higher levels of IL-1 receptor antagonist (IL-1Ra) at all time points leading

129 Naturally-occurring IL-1 receptor antagonist (IL-1Ra) binds and blocks the IL-1 r

130 The IL-1 receptor antagonist (IL-1Ra) has emerged as a pivotal pl

131 Systemically administered IL-1 receptor antagonist (IL-1RA) was protective against, and

132 osis factor-alpha (TNF-alpha), interleukin-1 receptor antagonist (IL-1RA), and transforming growth fa

133 Selected mice were treated with IL-1 receptor antagonist (IL-1RA), anti-IL-1beta, or recombin

134 get gene, Il1rn, which encodes interleukin-1 receptor antagonist (IL-1Ra), is sufficient to reverse I

135 c B cells, plasmablasts, and IL-10- and IL-1 receptor antagonist (IL-1RA)-producing Breg cells were i

136 t prevented in IL-1RI(-/-) mice, nor by IL-1 receptor antagonist (IL-1RA; 10 mg/kg).

137 (IL-1 receptor antagonist (IL-1Ra) and IL-36 receptor antagonist (IL-36Ra)), and two members that bro

138 ers that suppress inflammation: two specific receptor antagonists (IL-1 receptor antagonist (IL-1Ra)

139 -33, IL-36alpha, IL-36beta, and IL-36gamma), receptor antagonists (IL-1Ra, IL-36Ra), and 2 anti-infla

140 osis factor-alpha [TNF-alpha], interleukin-1 receptor antagonist [IL-1RA], and transforming growth fa

141 tem and chemotactic signaling (interleukin-1 receptor antagonist [IL-1Ra], IL-6, IL-8, macrophage inf

142 us, with the recombinant interleukin-1 (IL1) receptor antagonist (IL1RA) anakinra.

143 induction, 1635 (32%) received interleukin 2 receptor antagonist (IL2-RA), and 2596 (50%) received no

144 bulin (rATG); (2) Alemtuzumab (C1H); (3) IL2-receptor antagonists (IL2-RA; basiliximab or daclizumab)

145 1999-2016 who received ATG or interleukin-2 receptor antagonist (IL2RA) for induction.

146 1999-2016 who received ATG or interleukin-2 receptor antagonist (IL2RA) for induction.

147 or+ACE inhibitor or ARB+BB+mineralocorticoid receptor antagonist, implantable cardiac defibrillator+A

148 ore, in vivo treatment with the neurokinin-1 receptor antagonist in DED mice effectively restored Tre

149 herapy, with addition of a mineralocorticoid receptor antagonist in patients with persistent symptoms

150 tudies, such as the Study with an Endothelin Receptor Antagonist in Pulmonary Arterial Hypertension t

151 ated protein C, talactoferrin, interleukin-1 receptor antagonist in sepsis, and muscle relaxants in s

152 respecified as part of the Mineralocorticoid Receptor Antagonist in Type 2 Diabetes (MIRAD) trial, wh

153 use of intracerebroventricular (ICV) galanin receptor antagonists in prior studies precluded defining

154 rt a potential role for selective endothelin receptor antagonists in protecting renal function in pat

155 dings, and iontophoresis of serotonin (5-HT) receptor antagonists in the mouse visual cortex.

156 tamate signaling using subtype-specific NMDA receptor antagonists in vitro and in vivo We report that

157 and safety of ZPL-3893787 (a selective H(4) receptor antagonist) in patients with moderate-to-severe

158 of BMP2 and soluble VEGFR1 (sVEGFR1), a VEGF receptor antagonist, in a hydrogel skewed differentiatio

159 omising data with anakinra, recombinant IL-1 receptor antagonist, in patients with ST-segment-elevati

160 norbinaltorphimine, a selective kappa opioid receptor antagonist, in the BLA reduced alcohol consumpt

161 the gepants: calcitonin gene-related peptide receptor antagonists, in a preclinical model of medicati

162 ckers, ACE inhibitors, and mineralocorticoid receptor antagonists increase ACE2 receptor expression,

163 Conversely, GABA(A) and GABA(B) receptor antagonists increased the stretch response.

164 ethylphenidate and sulpiride, a selective D2 receptor antagonist, increased cognitive motivation more

165 exercise with either saline or BQ-123 (ET(A) receptor antagonist) infusion following a 2-week withdra

166 am of CD39 using the selective adenosine A2a receptor antagonist istradefylline.

167 ent receptor occupancy studies with the P2X7 receptor antagonist JNJ-54175446 were obtained in rhesus

168 aximal inhibitory concentration) of the P2X7 receptor antagonist JNJ-64413739 is 1.0 +/- 0.2 nM and 2

169 the highest potency and selectivity as A(3) receptor antagonist (K(i) = 258 nM).

170 The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine is associated with rapid bu

171 ressant efficacy of the N-methyl-D-aspartate receptor antagonist, ketamine, for treating major depres

172 Anakinra, IL-1 receptor antagonist, limited metastasis, and MDSC recrui

173 ong-acting beta2-agonist [LABA], leukotriene receptor antagonist [LTRA], theophylline, or long-acting

174 GLT2i empagliflozin (25 mg), 3) the glucagon receptor antagonist LY2409021 (300 mg), or 4) the combin

175 Combined subeffective doses of the mGlu(2/3) receptor antagonist LY341495 and (2R,6R)-HNK exerted syn

176 The endothelin receptor antagonist macitentan has demonstrated long-ter

177 on or oesophagitis, whereas the neurokinin-1 receptor antagonist maropitant citrate is licensed as an

178 val of excessive extracellular ATP, or P2Y11 receptor antagonists may be potential therapeutic strate

179 Peripherally restricted CB1 receptor antagonists may be useful in treating metabolic

180 ata suggest that N-methyl-D-aspartate (NMDA) receptor antagonists may block corticosteroid effect on

181 uggest that some medications, such as opioid-receptor antagonists, may be helpful.

182 The uncompetitive low-affinity NMDA receptor antagonist, memantine, acutely increases electr

183 s, increased interleukin 6 and interleukin 1 receptor antagonist messenger RNA, alterations in synapt

184 ng factor antagonists and the glucocorticoid receptor antagonist mifepristone, the HPT axis-based tre

185 We administered the NMDA receptor antagonist MK-801 and the GABA(A) receptor anta

186 Moreover, NMDA receptor antagonists MK-801 and memantine prevented seiz

187 onist, cetirizine, and cysteinyl-leukotriene receptor antagonist, montelukast, as well as between bas

188 ce-based treatment using a mineralocorticoid receptor antagonist (MRA) and with longitudinal systolic

189 (ARNI), beta-blocker, and mineralocorticoid receptor antagonist (MRA) were examined at baseline and

190 sis in myocardium, and MR (mineralocorticoid receptor) antagonists (MRAs) improve cardiac function by

191 Three drug classes (mineralocorticoid receptor antagonists [MRAs], angiotensin receptor-nepril

192 ignificant increase in IL-1RA (interleukin 1 receptor antagonist) mRNA expression and a decrease in R

193 taE), the most potent nicotine acetylcholine receptor antagonist (nAChR) of the Erythrina family, is

194 MCAM (0.1-0.32 mg/kg) or the opioid receptor antagonist naltrexone (0.001-0.032 mg/kg) was i

195 New forms of the opioid receptor antagonist naltrexone are also being studied.

196 l (1/0.1 mM) into unilateral PL and the AMPA receptor antagonist NBQX (1 mM) into contralateral or ip

197 imary ADP secretion are blocked by the NAADP receptor antagonist Ned-19, and reciprocally both are st

198 characterize the inhibitory activity of P2X1 receptor antagonists, NF279 and NF449, in cell lines, pr

199 The purinergic P2X1 receptor antagonist NF449, the purinergic P2X7 receptor

200 -initiating cell assay, with or without NK-A receptor antagonist (NK2), showed a suppressive effect o

201 Intrathecal injection of oxytocin receptor antagonist not only attenuates ejaculation but

202 The 5-HT3 receptor antagonist ondansetron is a good candidate for

203 ng in vivo using either a small molecule BMP receptor antagonist or a solubilized BMPR1a-FC receptor

204 findings may have implications for glucagon receptor antagonist or agonist-based therapies.

205 H-DPAT are blocked by co-infusion of an AMPA receptor antagonist or an anti-BDNF neutralizing antibod

206 ehavior of larvae either treated with a GABA receptor antagonist or carrying a mutation that eliminat

207 Administration of a glucocorticoid receptor antagonist or DC-specific Tsc22d3 deletion reve

208 s are associated with elevated interleukin-1 receptor antagonist or interleukin-8 and 2) whether bila

209 This action was not replicated by NMDA receptor antagonists or a chemical variant of ketamine t

210 on of neutrophils, suggesting that serotonin-receptor antagonists or serotonin reuptake inhibitors co

211 inistration of either dextromethorphan (NMDA receptor antagonist) or placebo across two sessions in a

212 GB-IL were mitigated with exendin-9, a GLP-1 receptor antagonist, or cholestyramine, a bile acid sequ

213 or crossover trials of 5HT(4) agonists, D(2) receptor antagonist, or ghrelin agonists; trials that me

214 Oxytocin receptor antagonists (OTR-A) have been developed as toco

215 mmunomodulatory mechanisms of the purinergic receptor antagonist oxidized ATP (oATP).

216 , r = -0.250, respectively), as well as IL-1 receptor antagonist (P < 0.01, r = -0.232 at the beginni

217 ue to explore new applications of endothelin receptor antagonists, particularly in treatment-resistan

218 e), dopamine agonists and the growth hormone receptor antagonist pegvisomant.

219 are also reduced by anaesthesia and the AMPA receptor antagonist perampanel, respectively.

220 dicates that radiolabeled somatostatin (sst) receptor antagonists perform better than agonists in det

221 tory effects on signals elicited by the NMDA-receptor antagonists phencyclidine (PCP) and ketamine.

222 e mutation imparts resistance to the GABA(A) receptor antagonist picrotoxin, allowing verification of

223 nt with Ketanserin (a selective serotonin 2A receptor antagonist) plus LSD in a double-blind, randomi

224 roglia using the colony stimulating factor 1 receptor antagonist PLX5622 from the brain and spinal co

225 ering the CSF1R (colony-stimulating factor 1 receptor) antagonist PLX5622 before and during the 14 d

226 , 0.70 [95% CI, 0.55-0.90]); and aldosterone receptor antagonist prescription (OR, 0.46 [95% CI, 0.22

227 es in BLA neurons seen in OTCs, while a Y(5) receptor antagonist prevented NPY's effects both on beha

228 NMDA receptor antagonists prevented medullary SD and apnea, w

229 include proton pump inhibitors, histamine-2 receptor antagonists, prokinetics, and central neuromodu

230 Icatibant, a bradykinin B(2) receptor antagonist, promotes MC degranulation via MRGPR

231 We probed the effects of the beta-adrenergic receptor antagonist propranolol (40 mg) using a between-

232 the decoy receptor IL-1 receptor 2 and IL-1 receptor antagonist protein (IL1Ra).

233 n distance was decreased when the purinergic receptor antagonists pyridoxalphosphate-6-azophenyl-2',4

234 reticulospinal cell responses whereas the D2 receptor antagonist raclopride increased the response am

235 epended on dopamine, because giving D1/D2/D3 receptor antagonists reduced these behaviors, but also p

236 a nonsteroidal, selective mineralocorticoid receptor antagonist, reduced albuminuria in short-term t

237 inhibition of FGFR1 activity by a selective receptor antagonist reduces alcohol drinking, when given

238 S44819, a selective GABA(A) alpha5 receptor antagonist, reduces tonic post-ischaemic inhibi

239 METx is a weak OT receptor antagonist, reducing the frequency of OT induce

240 nvasion or systemic administration of an EP2 receptor antagonist relieves multiple deleterious conseq

241 he first potent, non-acidic, allosteric P2X1 receptor antagonists reported to date.

242 blocker, beta-blocker, and mineralocorticoid receptor antagonist, respectively.

243 outcomes for non-metastatic PC with androgen receptor antagonists, respectively.

244 ith the oral calcitonin gene-related peptide receptor antagonist rimegepant resulted in a higher perc

245 tment of mutant mice with the glucocorticoid receptor antagonist RU486 restored KLF15 and POX express

246 A combination of olanzapine and the opioid receptor antagonist samidorphan is under development for

247 s facilitated by the nonselective muscarinic receptor antagonist scopolamine as well as the more subt

248 treatment of homozygous mouse pups with NMDA receptor antagonists significantly delayed the onset of

249 The mineralocorticoid and androgen receptor antagonist spironolactone (SP) was recently ide

250 only the latter was attenuated by the V(1a) receptor antagonist, SR49059 (1 mg/kg intraperitoneal).

251 Microinjection of the glycine receptor antagonist strychnine (4 mm, 100 nL) into the R

252 ations on the emerging use of vasopressin V2 receptor antagonists such as tolvaptan as safe and effec

253 tor antagonist, but not an NMDA/AMPA/kainate receptor antagonist, suggesting that they were mediated

254 bodies as well as by nicotinic acetylcholine receptor antagonists, suggesting that these receptors, i

255 receptor agonist bromocriptine or a dopamine receptor antagonist sulpiride (dopamine study n = 59) an

256 The nonselective orexin receptor antagonist suvorexant has been the first drug o

257 er core, AD was combined with an angiotensin receptor antagonist, Telmisartan (TS), which is known to

258 1-methylcyclopropene (1-MCP) in an ethylene receptor antagonist that blocks ethylene perception and

259 egepant is a calcitonin gene-related peptide receptor antagonist that has shown efficacy and safety i

260 ropranolol is a nonselective beta-adrenergic receptor antagonist that is efficacious in reducing faci

261 rolutamide is a structurally unique androgen-receptor antagonist that is under development for the tr

262 ll-molecule, calcitonin gene-related peptide receptor antagonist that may be effective in acute migra

263 of ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist that produces rapid and sustained an

264 of C-reactive protein (CRP), IL6, IL18, IL1 receptor antagonist, TNFalpha, leptin, adiponectin, fibr

265 or-neprilysin inhibitor+BB+mineralocorticoid receptor antagonist to implantable cardiac defibrillator

266 emonstrated the ability of ketamine, an NMDA receptor antagonist, to induce rapid (within hours), tra

267 ach has been applied to enzyme inhibitors or receptor antagonists, to date it remains unprecedented f

268 erate-to-severe CRS is managed with the IL-6 receptor antagonist tocilizumab with or without corticos

269 er growth alone and in synergy with androgen-receptor antagonist treatment in vivo.

270 t is an oral calcitonin gene-related peptide receptor antagonist under investigation for acute treatm

271 cule, calcitonin gene-related peptide (CGRP) receptor antagonist under investigation for treatment of

272 CORT125134 is a new selective glucocorticoid receptor antagonist under investigation.

273 Naltrexone is a nonselective opioid receptor antagonist used as a treatment for alcohol use

274 A xanthine oxidase inhibitor or IL-1 receptor antagonist was administered during RSV infectio

275 gender, and primary diagnosis, interleukin-1 receptor antagonist was higher on study days 1 and 2 in

276 Introduction of NMDA receptor antagonists was correlated with a decrease in s

277 bromide (IEM-1460), a calcium-permeable AMPA receptor antagonist, was determined.

278 Using a selective endothelin-1 receptor antagonist, we demonstrated for the first time

279 Employing purinergic receptor antagonists, we demonstrate that evoked ATP rel

280 Using BAPTA loading and selective receptor antagonists, we found that Ca(2+) mobilization

281 Finally, early acute levels of interleukin 1 receptor antagonist were associated with the number of d

282 ratio of those using long-acting muscarinic receptor antagonist were higher than those in the group

283 ng the synthesized compounds, selective A(3) receptor antagonists were found.

284 factor [TNF] and IL-1beta) and their soluble receptors/antagonists were examined.

285 ave been previously attributed to endothelin receptor antagonists, were more frequent in the atrasent

286 mine, a non-competitive N-methyl-D-aspartate receptor antagonist, which produces rapid and long-lasti

287 a potent, selective, and brain-penetrant V1a receptor antagonist, which was not suitable for full dev

288 It was suppressed by P2Y12 receptor antagonists, which also reduced process length

289 TP application and inhibitions by purinergic receptor antagonists, whole cell patch-clamp recordings

290 uine (HCQ), an orally administered Toll-like receptor antagonist widely used in lupus including durin

291 Methocinnamox (MCAM), a mu opioid receptor antagonist with a long duration of action, atte

292 nt, highly selective, and reversible P2Y(12) receptor antagonist with a rapid onset and short duratio

293 ethadone; REL-1017) is a noncompetitive NMDA receptor antagonist with an apparently favorable safety

294 We found that UBP-310, a kainate receptor antagonist with high selectivity for GluK1 subu

295 s suggest that the combination of a dopamine receptor antagonist with radiation enhances the efficacy

296 fety of pitolisant, a selective histamine H3 receptor antagonist with wake-promoting effects, for the

297 tain PZ-1361, a potent and selective 5-HT(7) receptor antagonist, with antidepressant properties in r

298 These included four dopamine D2 receptor antagonists, with D2 receptors having previousl

299 ion evoked swimming, and injection of a D(1) receptor antagonist within the middle rhombencephalic re

300 tigated whether gepants, small molecule CGRP receptor antagonists, worsen cerebral ischemia.